Addition Therapeutics
PrivateLast Round
Series A
Extension
Dec 22, 2025
Total Funding Raised
$106M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Addition Therapeutics is a biotechnology company developing a new class of genomic medicines using its all-RNA, non-viral, LNP-based PRINT (Precise RNA-Mediated Insertion of Transgenes) platform to create one-time therapies for chronic and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Addition Therapeutics Comparables
Compare Addition Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fractyl Health | 77% | |
| Remedium Bio | 77% | |
| Amgen | 67% | |
Addition Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 22, 2025 | ||||
| Series A | Sep 1, 2023 |
Addition Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BEVC | Series A, Series A Extension |
| Gates Family Foundation | Series A Extension |
| Osage University Partners | Series A, Series A Extension |
| Gates Foundation | Series A Extension |
| Abingworth | Series A, Series A Extension |
| Bill & Melinda Gates Foundation | Series A, Series A Extension |
| Pivotal bioVenture Partners | Series A, Seed, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Developing a gene therapy for permanent GLP-1 production in liver cells.
- Dec 22, 2025
$100M Series A round completed.
Addition Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Addition Therapeutics's valuation, stock price, and market status.